Baidu
map

我国公布2018年下半年深化医改重点工作任务清单

2018-08-29 王秉阳、王宾 新华网

提高基本医保和大病保险保障水平、推动开展医保目录内抗癌药集中采购……近日,国务院办公厅印发《深化医药卫生体制改革2018年下半年重点工作任务》(以下简称《工作任务》),以人民健康为中心,推动医改向纵深发展。

提高基本医保和大病保险保障水平、推动开展医保目录内抗癌药集中采购……近日,国务院办公厅印发《深化医药卫生体制改革2018年下半年重点工作任务》(以下简称《工作任务》),以人民健康为中心,推动医改向纵深发展。

“《工作任务》是引领医改继续前进的重要文件,具有鲜明的导向性、承续性。”中国人民大学医改研究中心主任王虎峰表示,《工作任务》围绕5项基本医疗卫生制度,坚持医疗、医保、医药三医联动,突出体现了在新形势、新挑战下改革的创新思路,有助于推动医改向精细化、制度化发展。

为加快优质医疗资源上下联动,《工作任务》提出有序推进分级诊疗制度建设。进一步规范医疗联合体建设和发展,完善医疗联合体建设和分级诊疗考核;推进家庭医生签约服务,完善激励机制,优先做好重点人群签约服务,做实做细服务等。

在建立健全现代医院管理制度方面,《工作任务》明确,深化医疗服务价格改革。加快建立以成本和收入结构变化为基础、及时灵活的价格动态调整机制,通过规范诊疗行为,降低药品、医用耗材等费用腾出空间,优化调整医疗服务价格。允许地方采取适当方式有效体现药事服务价值。

怎样在让老百姓“看得起病”的同时保障医保资金可持续?《工作任务》提出,提高基本医保和大病保险保障水平,居民基本医保人均财政补助标准再增加40元,一半用于大病保险。同步提高个人缴费标准。在全国全面推开按病种付费改革,统筹基本医保和大病保险,逐步扩大按病种付费的病种数量等。

对于人民群众高度关注的药品供应保障问题,《工作任务》强调,配合抗癌药降税政策,推进各省(自治区、直辖市)开展医保目录内抗癌药集中采购,对医保目录外的独家抗癌药推进医保准入谈判。开展国家药品集中采购试点,明显降低药品价格。

此外,《工作任务》还对加强综合监管制度建设、建立优质高效的医疗卫生服务体系等作出要求。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1814687, encodeId=573f181468ed5, content=<a href='/topic/show?id=306395888be' target=_blank style='color:#2F92EE;'>#重点工作任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95888, encryptionId=306395888be, topicName=重点工作任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Nov 30 16:17:00 CST 2018, time=2018-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945507, encodeId=4b1d194550ef1, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Sep 22 14:17:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775856, encodeId=2f451e7585693, content=<a href='/topic/show?id=7864660e9be' target=_blank style='color:#2F92EE;'>#深化医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66079, encryptionId=7864660e9be, topicName=深化医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1e138833678, createdName=lsndxfj, createdTime=Tue Nov 27 00:17:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287025, encodeId=ba4c128e025b4, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Fri Aug 31 05:17:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341632, encodeId=d5d0341632c6, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Aug 29 16:04:22 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1814687, encodeId=573f181468ed5, content=<a href='/topic/show?id=306395888be' target=_blank style='color:#2F92EE;'>#重点工作任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95888, encryptionId=306395888be, topicName=重点工作任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Nov 30 16:17:00 CST 2018, time=2018-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945507, encodeId=4b1d194550ef1, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Sep 22 14:17:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775856, encodeId=2f451e7585693, content=<a href='/topic/show?id=7864660e9be' target=_blank style='color:#2F92EE;'>#深化医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66079, encryptionId=7864660e9be, topicName=深化医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1e138833678, createdName=lsndxfj, createdTime=Tue Nov 27 00:17:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287025, encodeId=ba4c128e025b4, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Fri Aug 31 05:17:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341632, encodeId=d5d0341632c6, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Aug 29 16:04:22 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1814687, encodeId=573f181468ed5, content=<a href='/topic/show?id=306395888be' target=_blank style='color:#2F92EE;'>#重点工作任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95888, encryptionId=306395888be, topicName=重点工作任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Nov 30 16:17:00 CST 2018, time=2018-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945507, encodeId=4b1d194550ef1, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Sep 22 14:17:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775856, encodeId=2f451e7585693, content=<a href='/topic/show?id=7864660e9be' target=_blank style='color:#2F92EE;'>#深化医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66079, encryptionId=7864660e9be, topicName=深化医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1e138833678, createdName=lsndxfj, createdTime=Tue Nov 27 00:17:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287025, encodeId=ba4c128e025b4, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Fri Aug 31 05:17:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341632, encodeId=d5d0341632c6, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Aug 29 16:04:22 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1814687, encodeId=573f181468ed5, content=<a href='/topic/show?id=306395888be' target=_blank style='color:#2F92EE;'>#重点工作任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95888, encryptionId=306395888be, topicName=重点工作任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Nov 30 16:17:00 CST 2018, time=2018-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945507, encodeId=4b1d194550ef1, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Sep 22 14:17:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775856, encodeId=2f451e7585693, content=<a href='/topic/show?id=7864660e9be' target=_blank style='color:#2F92EE;'>#深化医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66079, encryptionId=7864660e9be, topicName=深化医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1e138833678, createdName=lsndxfj, createdTime=Tue Nov 27 00:17:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287025, encodeId=ba4c128e025b4, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Fri Aug 31 05:17:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341632, encodeId=d5d0341632c6, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Aug 29 16:04:22 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2018-08-31 tidiq
  5. [GetPortalCommentsPageByObjectIdResponse(id=1814687, encodeId=573f181468ed5, content=<a href='/topic/show?id=306395888be' target=_blank style='color:#2F92EE;'>#重点工作任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95888, encryptionId=306395888be, topicName=重点工作任务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Nov 30 16:17:00 CST 2018, time=2018-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945507, encodeId=4b1d194550ef1, content=<a href='/topic/show?id=f7cb9588e49' target=_blank style='color:#2F92EE;'>#重点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95887, encryptionId=f7cb9588e49, topicName=重点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Sep 22 14:17:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775856, encodeId=2f451e7585693, content=<a href='/topic/show?id=7864660e9be' target=_blank style='color:#2F92EE;'>#深化医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66079, encryptionId=7864660e9be, topicName=深化医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1e138833678, createdName=lsndxfj, createdTime=Tue Nov 27 00:17:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287025, encodeId=ba4c128e025b4, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Fri Aug 31 05:17:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341632, encodeId=d5d0341632c6, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Wed Aug 29 16:04:22 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2018-08-29 清风拂面

    谢谢分享学习

    0

相关资讯

2018下半年医改任务已定 互联网医疗将被纳入基本医保

2018下半年医改任务已定,互联网医疗将被纳入基本医保。

英媒:中国医改正帮助全球制药集团提振销售

因为已扩大的国家医保和加快的新药审批速度正提振他们在中国这个世界第二大药品市场的销售。

太原医改:交出“成绩单” 收获“幸福感”

A- A+ 太原市聚焦重点领域和关键环节,全面推进医药卫生体制改革,持续深化县乡医疗卫生机构一体化改革,使医疗机构内生动力不断增强、医疗资源持续下沉、分级诊疗落地见效、健康扶贫扎实推进、群众看病就医负担持续减轻。

推动惠医举措落地 全面加强队伍建设

8月27日,国家卫生健康委员会、国家中医药管理局联合发布的《关于学习贯彻习近平总书记重要指示精神 进一步加强医务人员队伍建设的通知》

持续加大“三医联动”改革力度

2018年全国医改工作电视电话会议8月27日在京召开。中共中央政治局常委、国务院总理李克强作出重要批示。

新一轮医药降费窗口期正在到来

如今,我国药物经济学在药物一致性评价、药品定价、医保目录调整、药品谈判等政策领域的应用正在快速增加。

Baidu
map
Baidu
map
Baidu
map